Buy LLY by Nov 3, 2026.

$LLY Q2 2026: Revenue: $22.97B vs. $20.26B expected Revenue growth: +48% Non-GAAP EPS: $8.38 vs. $6.01 expected Reported net income: $7.10B, up 25% Non-GAAP net income: $7.49B, up 32% The main drivers were Mounjaro and Zepbound. Mounjaro revenue rose 91% to $9.94B. U.S. Mounjaro revenue rose 45% to $4.8B. International Mounjaro revenue rose 172% to $5.2B. Zepbound U.S. revenue rose 44% to $4.9B. Volume growth was strong, but pricing was still a pressure point. Worldwide revenue was helped by a …